Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib

Reichardt, Peter; Kang, Yoon-Koo; Rutkowski, Piotr; Schuette, Jochen; Rosen, Lee; Seddon, Beatrice; YALÇIN, ŞUAYİB; Gelderblom, Hans; Williams, Charles; Fumagalli, Elena; Biasco, Guido; Hurwitz, Herbert; Kaiser, Pamela; Fly, Kolette; Matczak, Ewa; Chen, Liang; Lechuga, Maria; Demetri, George

doi:10.1002/cncr.29220

Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib

Reichardt P., Kang Y., Rutkowski P., Schuette J., Rosen L. S., Seddon B., ...Daha Fazla

CANCER, cilt.121, sa.9, ss.1405-1413, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 121 Sayı: 9
Basım Tarihi: 2015
Doi Numarası: 10.1002/cncr.29220
Dergi Adı: CANCER
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1405-1413
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUNDThe objectives of this study were to provide sunitinib to patients with gastrointestinal stromal tumor (GIST) who were otherwise unable to obtain it and to collect broad safety and efficacy data from a large population of patients with advanced GIST after imatinib failure.